International Journal of Clinical Pediatric Dentistry

Register      Login

VOLUME 5 , ISSUE 1 ( January-April, 2012 ) > List of Articles

RESEARCH ARTICLE

A Histopathological Comparison of Pulpal Response to Chitra-CPC and Formocresol used as Pulpotomy Agents in Primary Teeth: A Clinical Trial

N Ratnakumari, Bijimol Thomas

Keywords : Pulpotomy agent, Sree Chitra-Calcium Phosphate Cement, Formocresol

Citation Information : Ratnakumari N, Thomas B. A Histopathological Comparison of Pulpal Response to Chitra-CPC and Formocresol used as Pulpotomy Agents in Primary Teeth: A Clinical Trial. Int J Clin Pediatr Dent 2012; 5 (1):6-13.

DOI: 10.5005/jp-journals-10005-1126

License: CC BY-NC 4.0

Published Online: 00-04-2012

Copyright Statement:  Copyright © 2012; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Preventive measures have helped to minimize the occurrence of dental caries. However, premature loss of primary teeth on account of dental caries still remains a common problem among children. The pulpotomy technique has been the choice for treating vital primary and young permanent teeth with carious, mechanical and traumatic pulp exposures. The ideal pulpotomy medicament should be bioinductive or at least biocompatible, bactericidal and harmless to the pulp and surrounding structures. It should also promote healing of the radicular pulp and prevent bacterial microleakage with the least interference in the physiological process of root resorption. Since the best criteria for judging the effectiveness of a medicament when used for vital pulp therapy is the response that it produces in the pulp. The purpose of the present study was to evaluate and compare the response of human pulp tissue to recently developed Indian material, Sree Chitra-Calcium Phosphate Cement (Chitra-CPC) and formocresol, used as pulpotomy agent in deciduous teeth. Chitra-CPC has been compared with formocresol, taking into account that formocresol is still considered the gold standard in primary tooth pulpotomy. The study was conducted among 10 children in the age group of 8 to 12 years focusing on 20 noncarious primary canines indicated for serial extraction. Each patient received two different pulpotomy procedures—one in each of the primary canines using formocresol and the other with Chitra-CPC as pulpotomy agents. After 70 days, the teeth were extracted and subjected to histological examination. The results did not reveal statistically significant difference between the two groups. But Chitra-CPC gave more favorable results, in respect of pulpal inflammation, dentin bridge formation, quality of dentin bridge and connective tissue in dentin bridge.


PDF Share
  1. Agamy HA, Bakry NS, Mounir MM, Avery DR. Comparison of mineral trioxide aggregate and formocresol as pulp-capping agents in pulpotomized primary teeth. Pediatr Dent 2004;26(4): 302-309.
  2. Berger JE. Pulp tissue reaction to formocresol and zinc oxideeugenol. ASDC J Dent Child 1965;32:13-28.
  3. Chacko V, Kurikose S. Human pulpal response to mineral trioxide aggregate (MTA): A histologic study. J Clin Pediatr Dent 2006;30(3):203-209.
  4. Chaung HM, Hong CH, Chiang CP, Lin SK, Kuo YS, Lan WH, Hsieh CC. Comparison of calcium phosphate cement mixture and pure calcium hydroxide as direct pulp-capping agents. J Formos Med Assoc 1996;95(7):545-550.
  5. Doyle WA, McDonald RE, Mitchell DF. Formocresol versus calcium hydroxide in pulpotomy. J Dent Child 1962;29:86.
  6. Eidelman E, Holan G, Fuks AB. Mineral trioxide aggregate versus formocresol in pulpotomized primary molars: A preliminary report. Pediatr Dent 2001;23(1):15-18.
  7. Fernandez AC, Mohanty M, Varma HK, Komath M. Safety and efficacy of Chitra-CPC calcium phosphate cement as bone substitute. Current Science 2006;91(12):1678-1686.
  8. Friedberg BH, Gartner LP. Embryotoxicity and teratogenicity of formocresol on developing chick embryos. J Endod 1990;16(9); 434-437.
  9. Fuks AB. Current concepts in vital primary pulp therapy. Eur J Paediatr Dent 2002;3(3):115-120.
  10. Fuks AB. Pulp therapy for the primary dentition. In: Pinkham Jr (ed). Pediatric dentistry: Infancy Through Adolescence. 4th ed. Missouri: Saunders; 2005. 22 volume. 375-393 p.
  11. Fuks AB, Eidelman E, Cleaton-Jones P, Michaeli Y. Pulp response to ferric sulfate, diluted formocresol and IRM in pulpotomized primary baboon teeth. ASDC J Dent Child 1997;64(4):254-259.
  12. International Agency for Research on Cancer, World Health Organization (2004). IARC classifies formaldehyde as carcinogenic to humans. Available at: http://www.iarc.fr/ENG/press_Releases/archives/pr153a.html; 15 June 2005.
  13. Jean A, Kerebel B, Kerebel LM, LeGeros RZ, Hamel H. Effects of various calcium phosphate biomaterials on reparative dentin bridge formation. J Endod 1998;14(2):83-87.
  14. Karami B, Khayat A, Moazami F, Pardis S, Abbott P. Histological evaluation of the effect of three medicaments; trichloracetic acid, formocresol and mineral trioxide aggregate on pulpotomized teeth of dogs. Aust Endod J 2009;35(1):18-28.
  15. Komath M, Varma HK. Development of a fully injectable calcium phosphate cement for orthopedic and dental applications. Bull Mater Sci 2003;26(4):415-422.
  16. Komath M, Varma HK, Sivakumar R. On the development of an apatitic calcium phosphate bone cement. Bull Mater Sci 2000;23(2):135-140.
  17. Magnusson BO. Pulpotomy in primary molars: Long-term clinical and histological evaluation. Int Endod J 1980;13(3):143-155.
  18. Massler M, Mansukhani H. Effects of formocresol on dental pulp. J Dent Child 1959;26:277.
  19. Sena M, Yamashita Y, Nakano Y, Ohgaki M, Nakamura S, Yamashita K, Takagi Y. Octacalcium phosphate-based cement as a pulp-capping agent in rats. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;97(6):749-755.
  20. Srinivasan V, Patchett CL, Waterhouse PJ. Is there life after Buckley's Formocresol? Part 1- A narrative review of alternative interventions and materials. Inter J Paediatr Dent 2006;16(2): 117-127.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.